Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-10 · accession 0001883850-24-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-06-12 | 2024-06-10 | REGN | YANCOPOULOS GEORGE | Pres, CSO, Bd. Co-COB, Dir | G - Gift | $0.00 | -37.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-10 | G | A | 37,900 | $0.00 | 56,048 | I by Children | — | — | |
| 2 | Common | Common Stock | 2024-06-10 | G | D | 75,799 | $0.00 | 0 | I by 2022 GRAT II | — | — |